Arcturus Therapeutics Holdings (ARCT) Equity Ratio (2018 - 2025)
Historic Equity Ratio for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to 0.8.
- Arcturus Therapeutics Holdings' Equity Ratio rose 1257.53% to 0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8, marking a year-over-year increase of 1257.53%. This contributed to the annual value of 0.7 for FY2024, which is 798.18% up from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Equity Ratio is 0.8, which was up 1257.53% from 0.75 recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Equity Ratio registered a high of 0.8 during Q3 2025, and its lowest value of 0.5 during Q3 2022.
- In the last 5 years, Arcturus Therapeutics Holdings' Equity Ratio had a median value of 0.66 in 2023 and averaged 0.65.
- Examining YoY changes over the last 5 years, Arcturus Therapeutics Holdings' Equity Ratio showed a top increase of 21095.25% in 2021 and a maximum decrease of 3019.75% in 2021.
- Over the past 5 years, Arcturus Therapeutics Holdings' Equity Ratio (Quarter) stood at 0.58 in 2021, then increased by 3.31% to 0.6 in 2022, then rose by 8.07% to 0.65 in 2023, then increased by 7.98% to 0.7 in 2024, then rose by 13.56% to 0.8 in 2025.
- Its last three reported values are 0.8 in Q3 2025, 0.75 for Q2 2025, and 0.7 during Q1 2025.